Literature DB >> 1633476

Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology.

R J Wityk1, L R Caplan.   

Abstract

Hypertension is the major risk factor for intracerebral hemorrhage (ICH) and is present in about 50% of patients with ICH. Common clinical findings are focal neurologic deficits at onset, gradually progressive deterioration, and the presence of headache, vomiting, and depressed level of consciousness. The clinical syndromes of ICH at common locations are reviewed. CT scanning has dramatically changed our thinking about ICH and allowed better correlation of neurologic findings with lesions at various sites.

Entities:  

Mesh:

Year:  1992        PMID: 1633476

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  3 in total

Review 1.  Hemostatic therapy for intracerebral hemorrhage.

Authors:  Fred Rincon; Manuel M Buitrago; Stephan A Mayer
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

2.  Effect Western Medicines Combined With Nao-Xue-Shu in Patients With Hypertensive Intracerebral Hemorrhage: A Network Meta-Analysis.

Authors:  Li Mei; Mu Fengqun; Liu Xiaozhuo; Wang Qing; Fan Mingming; Zuo Zhengyao; Su Dongpo; Han Qian; Chen Tong
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

3.  Neuroprotective potential of solanesol in a combined model of intracerebral and intraventricular hemorrhage in rats.

Authors:  Kajal Rajdev; Ehraz Mehmood Siddiqui; Kuldeep Singh Jadaun; Sidharth Mehan
Journal:  IBRO Rep       Date:  2020-04-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.